Bone Therapeutics provides Third Quarter 2022 Business Update
REGULATED INFORMATION Mont-Saint-Guibert, Belgium, 21 October 2022, 7am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the cell therapy...
COVID-19
Jounce Therapeutics to Present Multiple Posters at the Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting and the European Society of Medical Oncology Immuno-Oncology (ESMO-IO) Annual Congress
- Two preclinical posters highlighting the JTX-1484 program and LILRB family at SITC 2022 - - Two clinical posters highlighting...
Summit Therapeutics Presents Ri-CoDIFy Trial Results for Microbiome-Sparing Ridinilazole at IDWeek 2022
Ridinilazole resulted in a 53% relative risk reduction in recurrence of C. difficile infection compared to treatment with vancomycin Ridinilazole...
Monte Rosa Therapeutics to Present at 5th Annual Targeted Protein Degradation Summit and 34th EORTC-NCI-AACR Symposium
– New and Updated Preclinical Data Highlight Potential of GSPT1-directed Molecular Glue Degrader (MGD) MRT-2359 in the Treatment of MYC-driven...
Nanox to Host and Livestream ‘ARC Day’ event: Company’s Demonstration of Nanox’s Ecosystem
ARC Day will publicly demonstrate Nanox’s end-to-end 3D medical imaging solution in-person and onlineNEVE ILAN, Israel, Oct. 20, 2022 (GLOBE NEWSWIRE)...
Hepion Pharmaceuticals Announces Publication of Food Effect Study with Rencofilstat
EDISON, N.J., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial...
P3 Health Partners Provides Second-Quarter and Year-to-Date 2022 Financial Results; Increases 2022 Revenue Outlook
Strong First-Half 2022 revenue growth of 84% compared to the First-Half 2021At-risk Medicare Advantage members exceeded 100,000 at the end...
Chembio Diagnostics to Report Third Quarter 2022 Financial Results on November 3, 2022
HAUPPAUGE, N.Y., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on...
MEDIROM Healthcare Technologies Inc. Announces September 2022 Key Performance Indicators (KPIs)
Total Customers Served: 71,770 – Sales Per Customer: JPY 6,505 – Customer Repeat Ratio: 80.8% September 2022_Number of Salons September...
Beyond Air® Schedules Second Fiscal Quarter 2023 Financial Results Conference Call and Webcast
Call scheduled for Tuesday, November 8ᵗʰ at 4:30 pm Eastern TimeGARDEN CITY, N.Y., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Beyond...
P3 Health Partners Announces Chief Financial Officer Transition Appoints Erin Darakjian as Interim CFO
HENDERSON, Nev., Oct. 20, 2022 (GLOBE NEWSWIRE) -- P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health...
Sensus Healthcare Introduces Silk™ Laser Hair Removal System
Only portable hair removal laser system with blended wavelengths for all skin phototypes to be launched at the Fall Clinical...
AMN Healthcare Survey: 85% of Healthcare Facilities Face Shortages of Allied Healthcare Professionals
DALLAS, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Eighty-five percent of hospitals, medical groups, home health providers and other healthcare facilities...
Evoke Pharma to Participate in the 2022 American College of Gastroenterology Annual Scientific Meeting
Company will exhibit Gimoti® and meet with Key Opinion Leaders Healio Industry Breakthrough Product Award Nominee SOLANA BEACH, Calif., Oct....
TOMI Environmental Receives Order From National Institutes of Health (NIH); TOMI Products Now Deployed in Over 20 NIH Facilities Across 11 Divisions
FREDERICK, Md., Oct. 20, 2022 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in...
Eyenovia Announces Positive Results from VISION-2 Phase 3 Study of MicroLine as a Potential On-Demand Treatment for Presbyopia
NEW YORK, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a pre-commercial ophthalmic technology company developing the Optejet®...
Erasca Announces Clinical Trial Collaboration and Supply Agreement with Pfizer to Evaluate ERAS-007 and Palbociclib Combination
ERAS-007, a potential best-in-class ERK1/2 inhibitor, is being evaluated in combination with palbociclib in patients with KRAS- and NRAS-mutant colorectal...
Excision BioTherapeutics to Host Key Opinion Leader Webinar on HIV and the Ongoing Phase 1/2 Trial Evaluating EBT-101 as a Potential Cure
Webinar will focus on the unmet medical need in HIV, therapeutic applications of gene delivery and editing for treatment of...
Sunshine Biopharma Announces the Acquisition of Nora Pharma, Adding $10.7 Million in Revenue
MONTREAL, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company focused on the research, development...
gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Improves Neurobehavioral Outcomes in a Model of Traumatic Brain Injury
Pre-clinical trial demonstrates ability of nVNS to decrease amount of brain injury, decrease anxiety and improve motor function post injuryROCKAWAY,...